These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model. Kwon HJ, Han SB, Kim BR, Kang KR, Huh DH, Choi GS, Ahn DH, Kang JH. BMC Infect Dis; 2017 Apr 04; 17(1):247. PubMed ID: 28376777 [Abstract] [Full Text] [Related]
16. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis. Sato H, Sato Y. Dev Biol Stand; 1985 Jul 18; 61():461-7. PubMed ID: 2872127 [Abstract] [Full Text] [Related]
17. Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis. Roduit C, Bozzotti P, Mielcarek N, Lambert PH, del Giudice G, Locht C, Siegrist CA. Infect Immun; 2002 Jul 18; 70(7):3521-8. PubMed ID: 12065491 [Abstract] [Full Text] [Related]
18. Serological responses to infection with B. pertussis. Giammanco A, Taormina S, Genovese M, Mangiaracina G, Giammanco G, Chiarini A. Dev Biol Stand; 1997 Jul 18; 89():213-20. PubMed ID: 9272353 [Abstract] [Full Text] [Related]